Episode Details

In this episode of TDR Cannabis in Five, host Shadd Dales breaks down a new study out of New York — first reported by Marijuana Moment — showing that medical cannabis patients significantly reduced their prescription opioid use, and kept those reductions going for well over a year. For anyone following the opioid crisis or the medical-cannabis conversation, this is an important development.Shadd explains how researchers analyzed verified prescription-monitoring data from 2018 through 2023, comparing chronic-pain patients who entered New York’s medical cannabis program to similar patients who did not. The results were clear: patients using medical cannabis lowered their average daily opioid dosage and maintained that drop over an 18-month period. And because the study relied on state-verified records rather than surveys, the findings hold more weight with clinicians and policymakers.He also breaks down what this could mean for doctors, insurance providers, and lawmakers as discussions continue around safer pain-management options. The episode highlights why this study stands out compared to typical cannabis research and how it could influence future access, federal scheduling debates, and medical guidance nationwide.#CannabisInFive #MedicalCannabis #Opioids #CannabisResearch #CannabisNews #ChronicPain #CannabisPolicy #CannabisIndustry #NewYorkCannabis #MMEWant to see more Cannabis Reform videos?   • Cannabis vs Alcohol & Pharma: What’s Reall...     • Dina Titus Demands Answers from Attorney G...     • Senator Blocks Trump Drug Czar Nominee | T...     • Why Cannabis Is Gaining Ground Clinically ...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter:   / thedalesreport  Instagram:

Listen Now